State Street
CAMP icon

State Street’s CAMP4 Therapeutics CAMP Stock Holding History

State Street’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Buy
146,900
+107,200
+270% +$509K ﹤0.01% 3593
2025
Q4 		$243K Buy
39,700
+13,700
+53% +$58.3K ﹤0.01% 3857
2025
Q3 		$78K Buy
+26,000
New +$48.2K ﹤0.01% 4091
2025
Q2 		– Sell
-26,236
Closed -$105K – 4270
2025
Q1 		$105K Buy
26,236
+5,736
+28% +$27.8K ﹤0.01% 3970
2024
Q4 		$107K Buy
+20,500
New +$168K ﹤0.01% 3975

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street's CAMP Position: Q1 2026 in Review

State Street increased its CAMP4 Therapeutics (CAMP) stake by 270% in Q1 2026, buying an estimated $509K and bringing the position to 146,900 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

State Street first reported a position in CAMP in Q4 2024 and has held it in 5 quarters since. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • State Street held 146,900 shares of CAMP4 Therapeutics worth $648K as of Q1 2026.
  • State Street bought 107,200 CAMP4 Therapeutics shares in Q1 2026, an estimated $509K.
  • CAMP4 Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3593 holding.
  • State Street first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.